MedPath

The effect of compound Ma-ol-asal on treatment of the adult asthma

Phase 3
Conditions
Asthma.
Asthma
Registration Number
IRCT20181115041664N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

mild to moderate asthma
18-60 years old
Referral to the pulmonary clinic of Loghman Hospital, Tehran, Iran

Exclusion Criteria

under 18 and over 60 years old
patients with severe asthma and require hospitalization
patients with underlying diseases such as CF,COPD, heart failure, GERD, bronchiectasis, Pulmonary embolism and sarcoidosis
Addicts to cigarettes
BMI > 29
pregnant and lactating women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath